Sandra Hammer

Sandra Hammer has a diverse work experience spanning various roles and institutions. Sandra began their career as an Undergraduate Student Researcher at the University of Miami from January 2008 to May 2011. Sandra then went on to Vanderbilt University, where they served as a PhD Graduate Candidate from August 2011 to December 2015. Sandra continued their research journey at Michigan State University, starting in February 2016, where they held roles as a Research Fellow and Senior Research Associate until March 2022. During their time at Michigan State University, they also served as Co-Chair of the Michigan State University Post Doctoral Association from January 2017 to March 2022. Most recently, starting in March 2022, Sandra has taken on the role of Science Program Manager at Atossa Therapeutics, Inc.

Sandra Hammer obtained their Bachelor's Degree in Biology, General from the University of Miami from 2007 to 2011. Following that, they pursued a Doctor of Philosophy (Ph.D.) in Cell and Developmental Biology specializing in retinal biology from Vanderbilt University School of Medicine, where they completed their studies from 2011 to 2016. Additionally, Sandra has obtained the "NIH Introduction to the Principles and Practice of Clinical Research Completion" certification from the National Institutes of Health (NIH): Intramural Research Program (IRP), although the specific month and year of completion are not mentioned.